Parry EM, Hacken ET, Wu CJ. Richter syndrome: novel insights into the biology of transformation. Blood. 2023;142(1):11-22. doi:10.1182/blood.2022016502
Publications
Isozaki H, Sakhtemani R, Abbasi A, et al. Therapy-induced APOBEC3A drives evolution of persistent cancer cells. Nature. 2023. doi:10.1038/s41586-023-06303-1
Voit RA, Sankaran VG. MECOM Deficiency: from Bone Marrow Failure to Impaired B-Cell Development. Journal of clinical immunology. 2023. doi:10.1007/s10875-023-01545-0
Andress C, Kappel K, Villena ME, Cuperlovic-Culf M, Yan H, Li Y. DAPTEV: Deep aptamer evolutionary modelling for COVID-19 drug design. PLoS computational biology. 2023;19(7):e1010774. doi:10.1371/journal.pcbi.1010774
Gibson CJ, Fell G, Sella T, et al. Clonal Hematopoiesis in Young Women Treated for Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023;29(13):2551-2558. doi:10.1158/1078-0432.CCR-23-0050
Oddsson A, Sulem P, Sveinbjornsson G, et al. Publisher Correction: Deficit of homozygosity among 1.52 million individuals and genetic causes of recessive lethality. Nature communications. 2023;14(1):3923. doi:10.1038/s41467-023-39492-4
Zhang T, Xu D, Liu J, et al. Prolonged hypoxia alleviates prolyl hydroxylation-mediated suppression of RIPK1 to promote necroptosis and inflammation. Nature cell biology. 2023. doi:10.1038/s41556-023-01170-4
Wong WJ, Emdin C, Bick AG, et al. Author Correction: Clonal haematopoiesis and risk of chronic liver disease. Nature. 2023. doi:10.1038/s41586-023-06375-z
Tekle GE, Garrett WS. Bacteria in cancer initiation, promotion and progression. Nature reviews. Cancer. 2023. doi:10.1038/s41568-023-00594-2
Mayuranathan T, Newby GA, Feng R, et al. Potent and uniform fetal hemoglobin induction via base editing. Nature genetics. 2023. doi:10.1038/s41588-023-01434-7